BioBridgeXAll companies

Promakhos Therapeutics Inc.

Biotechnology company · Sommerville, Massachusetts, United States

Promakhos Therapeutics Inc. is a biotechnology company headquartered in Sommerville, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $271,865 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2.2 million sold in a notice filed in 2022.

www.promakhos.comProfile compiled from public records. Is this your company? Request a correction or update

Promakhos Therapeutics at a glance

Typebiotechnology company
HeadquartersSommerville, Massachusetts, United States
Earliest incorporation on record2021
Employees (self-reported, 2023)2
SEC CIK1889681

What does Promakhos Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $271,865 in total (2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.2 million sold (2022).

Frequently asked questions about Promakhos Therapeutics

Where is Promakhos Therapeutics headquartered?

Promakhos Therapeutics Inc. is headquartered in Sommerville, Massachusetts, United States.

What does Promakhos Therapeutics do?

Promakhos Therapeutics Inc. is a biotechnology company.

When was Promakhos Therapeutics founded?

The earliest incorporation on record for Promakhos Therapeutics Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences